GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf1 | rn6_v1_chr10_+_23661343_23661343 | 0.22 | 5.1e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_139997537 Show fit | 77.63 |
ENSRNOT00000073207
|
|
|
chr6_-_140572023 Show fit | 54.32 |
ENSRNOT00000072338
|
|
|
chr7_-_119716238 Show fit | 51.72 |
ENSRNOT00000075678
|
interleukin 2 receptor subunit beta |
|
chr16_+_10417185 Show fit | 51.59 |
ENSRNOT00000082186
|
annexin A8 |
|
chr7_-_119712888 Show fit | 50.72 |
ENSRNOT00000077438
|
interleukin 2 receptor subunit beta |
|
chr17_-_31780120 Show fit | 49.11 |
ENSRNOT00000058388
|
|
|
chr1_+_219403970 Show fit | 48.48 |
ENSRNOT00000029607
|
protein tyrosine phosphatase, receptor type, C-associated protein |
|
chr6_-_143195143 Show fit | 47.49 |
ENSRNOT00000081337
|
|
|
chr20_+_4043741 Show fit | 46.70 |
ENSRNOT00000000525
|
RT1 class II, locus Bb |
|
chr10_+_84309430 Show fit | 44.77 |
ENSRNOT00000030159
|
src kinase associated phosphoprotein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 120.9 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
22.8 | 114.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
4.0 | 75.2 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
7.3 | 65.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
2.0 | 62.7 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
15.4 | 61.5 | GO:0030221 | basophil differentiation(GO:0030221) |
6.0 | 60.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
6.5 | 58.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
8.2 | 57.7 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
14.2 | 56.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 530.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.8 | 240.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.6 | 206.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
4.0 | 142.5 | GO:0008305 | integrin complex(GO:0008305) |
7.5 | 119.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 103.4 | GO:0030027 | lamellipodium(GO:0030027) |
3.1 | 95.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 90.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
4.8 | 82.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.6 | 72.6 | GO:0000791 | euchromatin(GO:0000791) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 201.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
3.0 | 161.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
6.0 | 150.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
4.5 | 120.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
4.6 | 116.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
36.9 | 110.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.1 | 87.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.8 | 82.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.0 | 77.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
2.1 | 73.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 194.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 168.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
3.1 | 159.4 | PID BCR 5PATHWAY | BCR signaling pathway |
4.0 | 139.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
4.1 | 119.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
3.2 | 92.6 | PID EPO PATHWAY | EPO signaling pathway |
1.4 | 85.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.5 | 78.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
5.3 | 74.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.3 | 71.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 187.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
3.4 | 147.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
3.1 | 147.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
3.3 | 109.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 89.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.2 | 78.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
2.9 | 71.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.9 | 70.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.6 | 69.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 63.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |